Avoid common mistakes on your manuscript.
![figure a](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-023-06478-9/MediaObjects/259_2023_6478_Figa_HTML.jpg)
A 54-year-old woman suspected of lung cancer underwent [18F]FDG and [18F]FAPI-74 PET scans. CT revealed a 7-cm lesion in the left upper lobe. Despite detecting only necrotic cells on biopsy during bronchoscopy, malignancy was strongly suspected, leading to a planned lobectomy.
[18F]FDG PET-CT showed a highly avid mass (SUVmax: 14.2) in the left upper lung lobe, along with suspicious lymph node metastases with mild uptake in the left hilar, thoracic para-aortic, and left supraclavicular regions (A: MIP; B: PET/CT fusion, left). Similarly, [18F]FAPI-74 PET-CT also showed intense uptake (SUVmax: 9.02) with heterogeneous distribution in the same lesion, but with slightly larger extent (A and B, right), and no significant uptake was observed in the lymph nodes. Some areas displayed faint to mild FAPI uptake mismatched with FDG.
Histopathology revealed epithelioid granuloma (C: arrows indicate Langhans giant cells in H&E staining), but results for Grocott stain, PAS stain, and Ziehl–Neelsen stain were all negative. Immunohistochemical staining for FAP showed some areas with FAP expression surrounding the necrotic tissue in heterogenous uptake on [18F]FAPI-74 PET (D).
FAPI, an emerging pan-tumour tracer, also accumulates in chronic infections, leading to false positives [1]. Literature supports FAPI PET/CT’s use in granulomatous conditions like tuberculosis [2,3,4]. The mismatch between FAPI and FDG accumulation may represent varying lesion stages. The FDG-avid lesion might represent an inflammatory-proliferative stage, while the FAPI-positive lesion could represent a fibrotic phase [5]. Evaluation of FAPI uptake in non-malignant tumours will expand the clinical utility of FAPI-PET across diverse scenarios.
References
Meetschen M, Sandach P, Darwiche K, Theegarten D, Moter A, Schaarschmidt BM, et al. Rabbit fever: granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer 18FDG and 68Ga-FAPI PET/CT. Eur J Nucl Med Mol Imaging. 2023;50:2567–9. https://doi.org/10.1007/s00259-023-06175-7.
Gu B, Luo Z, He X, Wang J, Song S. 68Ga-FAPI and 18F-FDG PET/CT images in a patient with extrapulmonary tuberculosis mimicking malignant tumor. Clin Nucl Med. 2020;45:865–7. https://doi.org/10.1097/RLU.0000000000003279. (Published online).
Liu H, Liu L, Chen L, Zhao Y, Zhang W, Cai L, et al. [68Ga]Ga-DOTA-FAPI-04 PET/CT imaging of benign pulmonary solitary fibrous tumour. Eur J Nucl Med Mol Imaging. 2021;48:2053–4. https://doi.org/10.1007/s00259-021-05199-1.
Hao B, Wu X, Pang Y, Sun L, Wu H, Huang W, et al. [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions. Eur J Nucl Med Mol Imaging. 2021;48:651–2. https://doi.org/10.1007/s00259-020-04941-5.
Jia G, Bian D, Cheng C, Wang M, Zuo C. The different manifestations of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in evaluation of the steroid therapy response for IgG4-related disease: a case report. Front Nucl Med. 2023;2. https://doi.org/10.3389/fnume.2022.1038797.
Funding
Open access funding provided by Osaka University.
Author information
Authors and Affiliations
Contributions
Conceptualisation: TW, ID, and FLG; data collection: TW, TK, TH, MT, SN, TK, EF, TK, NO, SF, and HK; original draft preparation: TW and ID; review and editing: YM, JC, and FLG; supervision: EM, YS, and FLG. All authors have read and agreed to the submitted version of the manuscript.
Corresponding author
Ethics declarations
Consent to participate
Written informed consent was obtained from the patient.
Conflict of interest
FLG is an advisor at ABX Radiopharmaceuticals, SOFIE Biosciences, Telix Pharma, and Alpha Fusion. FLG has shares in a consultancy group for iTheranostics. The other authors declare no potential conflicts of interest relevant to this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Watabe, T., David, I.R., Kimura, T. et al. Epithelioid granuloma mimicking lung cancer showed intense uptake on [18F]FAPI-74 PET. Eur J Nucl Med Mol Imaging 51, 930–931 (2024). https://doi.org/10.1007/s00259-023-06478-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-023-06478-9